Patents by Inventor Adnan Ahmed Kadi

Adnan Ahmed Kadi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N,N?-hydrazino-bis-isatin derivatives with selective activity against multidrug-resistant cancer cells
    Patent number: 8497296
    Abstract: The invention is directed to a compound of Formula (I), wherein R is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group; R1 is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group; X is selected from the group consisting of hydrogen atom or halogen atom; and Y is selected from the group consisting of hydrogen atom, halogen atom, C1-C4 alkyl group, nitro group, and —OCF3 group, as well as for its use in therapy, preferably for the treatment of cancer, and to a related pharmaceutical composition, the use of the compound for the manufacture of a medicament for the respective medical indication, and a method of synthesis of the compounds of the invention.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: July 30, 2013
    Assignee: King Saud University
    Inventors: Tarek Aboul-Fadl Mohamed Hassan, Adnan Ahmed Kadi, Hatem Abdel-Khader Abdel-Aziz
  • Novel N, N'-Hydrazino-bis-isatin Derivatives with Selective Activity Against Multidrug-Resistant Cancer Cells
    Publication number: 20120252860
    Abstract: The invention is directed to a compound of Formula (I), wherein R is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group; R1 is selected from the group consisting of hydrogen atom and unsubstituted or substituted phenyl group; X is selected from the group consisting of hydrogen atom or halogen atom; and Y is selected from the group consisting of hydrogen atom, halogen atom, C1-C4 alkyl group, nitro group, and —OCF3 group, as well as for its use in therapy, preferably for the treatment of cancer, and to a related pharmaceutical composition, the use of the compound for the manufacture of a medicament for the respective medical indication, and a method of synthesis of the compounds of the invention.
    Type: Application
    Filed: March 16, 2012
    Publication date: October 4, 2012
    Applicant: King Saud University
    Inventors: Tarek Aboul-Fadl Mohamed Hassan, Adnan Ahmed Kadi, Hatem Abdel-Khader Abdel-Aziz